0001209191-19-005262.txt : 20190124
0001209191-19-005262.hdr.sgml : 20190124
20190124210143
ACCESSION NUMBER: 0001209191-19-005262
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190122
FILED AS OF DATE: 20190124
DATE AS OF CHANGE: 20190124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FELLOWS DAVID A
CENTRAL INDEX KEY: 0001041126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38217
FILM NUMBER: 19541078
MAIL ADDRESS:
STREET 1: 2525 DUPONT DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nightstar Therapeutics plc
CENTRAL INDEX KEY: 0001711675
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: C/O NIGHTSTAR, INC.
STREET 2: 203 CRESCENT STREET, SUITE 303
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 781-778-7553
MAIL ADDRESS:
STREET 1: C/O NIGHTSTAR, INC.
STREET 2: 203 CRESCENT STREET, SUITE 303
CITY: WALTHAM
STATE: MA
ZIP: 02453
FORMER COMPANY:
FORMER CONFORMED NAME: Nightstar Therapeutics Ltd
DATE OF NAME CHANGE: 20170712
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-22
0
0001711675
Nightstar Therapeutics plc
NITE
0001041126
FELLOWS DAVID A
C/O NIGHTSTAR, INC.
203 CRESCENT STREET, SUITE 303
WALTHAM
MA
02453
1
1
0
0
Chief Executive Officer
Stock Option (Right to Buy)
14.74
2019-01-22
4
A
0
271100
0.00
A
2029-01-21
Ordinary Shares
271100
271100
D
This option will vest as to 25% on January 1, 2020. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.
The ordinary shares, nominal value GBP 0.01 per share, of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.
/s/ Bryan Yoon, Attorney-in-Fact
2019-01-24